Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cystic Fibrosis

fluorodeoxyglucose f18 has been researched along with Cystic Fibrosis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (71.43)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atkinson, JJ; Chen, DL; Ferkol, TW	1
Armoni, S; Chisin, R; Cohen-Cymberknoh, M; Freedman, N; Kerem, E; Klein, M; Orevi, M; Shoseyov, D	1
Amin, R; Charron, M; Ciet, P; Graniel, K; Grasemann, H; Grinblat, L; Ratjen, F; Shammas, A; Tiddens, H	1
Dolovich, MB; Freitag, AP; Labiris, NR; Nahmias, C; Thompson, ML	1
Chen, DL; Ferkol, TW; Mintun, MA; Pittman, JE; Rosenbluth, DB; Schuster, DP	1
Dolovich, MB; Schuster, DP	1
Martinez, S; McAdams, HP; Youens, KE	1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and Cystic Fibrosis

Article	Year
FDG PET imaging in cystic fibrosis. Seminars in nuclear medicine, 2013, Volume: 43, Issue:6 Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Discovery; Fluorodeoxyglucose F18; Humans; Lung; Positron-Emission Tomography	2013
Positron emission tomography and computed tomography versus positron emission tomography computed tomography: tools for imaging the lung. Proceedings of the American Thoracic Society, 2007, Aug-01, Volume: 4, Issue:4 Topics: Cystic Fibrosis; Fluorodeoxyglucose F18; Glucose; Humans; Lung; Positron-Emission Tomography; Tomography, X-Ray Computed	2007

Other Studies

5 other study(ies) available for fluorodeoxyglucose f18 and Cystic Fibrosis

Article	Year
18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis. Chest, 2009, Volume: 136, Issue:5 Topics: Adolescent; Adult; Cystic Fibrosis; Disease Progression; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2009
Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology, 2012, Volume: 264, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Child; Cystic Fibrosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Tomography, X-Ray Computed	2012
Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation? The European respiratory journal, 2003, Volume: 21, Issue:5 Topics: Adult; Aged; Aminoglycosides; Cystic Fibrosis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neutrophil Activation; Pneumonia; Radiopharmaceuticals; Sputum; Tobramycin; Tomography, Emission-Computed	2003
Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. American journal of respiratory and critical care medicine, 2006, Jun-15, Volume: 173, Issue:12 Topics: Adult; Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Leukocyte Count; Lung; Male; Neutrophils; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution	2006
Kaposi sarcoma after bilateral lung transplantation. Journal of thoracic imaging, 2008, Volume: 23, Issue:1 Topics: Biopsy; Cystic Fibrosis; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Herpesvirus 8, Human; Humans; Lung; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Radiopharmaceuticals; Sarcoma, Kaposi; Tomography, X-Ray Computed	2008